It is possible that infiltrating T cells, positively selected in the thymus by virtue of expressing TCRs with a low/intermediate affinity for self-Ags, are indeed able to recognize such antigens on tumor cells, or that TCR/CAR-induced inflammatory environment promotes effector function by bystander cells via non-Ag-specific mechanisms (179–181). The gene discussed is RENBP; the disease is neoplasm.